Literature DB >> 14715483

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003.

Stephen F Hodgson, Nelson B Watts, John P Bilezikian, Bart L Clarke, T Kenney Gray, David W Harris, C Conrad Johnston, Michael Kleerekoper, Robert Lindsay, Marjorie M Luckey, Michael R McClung, Howard R Nankin, Steven M Petak, Robert R Recker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14715483     DOI: 10.4158/EP.9.6.544

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


× No keyword cloud information.
  86 in total

1.  Long-term effect of the Women's Health Initiative study on antiosteoporosis medication prescribing.

Authors:  Euni Lee; Mary K Maneno; Anthony K Wutoh; Ilene H Zuckerman
Journal:  J Womens Health (Larchmt)       Date:  2010-05       Impact factor: 2.681

2.  A nomogram for predicting osteoporosis risk based on age, weight and quantitative ultrasound measurement.

Authors:  C Pongchaiyakul; S Panichkul; T Songpatanasilp; T V Nguyen
Journal:  Osteoporos Int       Date:  2007-01-10       Impact factor: 4.507

3.  Bisphosphonate therapy: when not to monitor BMD.

Authors:  Umang Sharma; James J Stevermer
Journal:  J Fam Pract       Date:  2009-11       Impact factor: 0.493

4.  Use of osteoporosis medications in older nursing facility residents.

Authors:  Rollin M Wright
Journal:  J Am Med Dir Assoc       Date:  2007-08-13       Impact factor: 4.669

Review 5.  Update on bone density testing.

Authors:  E Michael Lewiecki
Journal:  Curr Osteoporos Rep       Date:  2005-12       Impact factor: 5.096

6.  Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women.

Authors:  V Rabenda; R Mertens; V Fabri; J Vanoverloop; F Sumkay; C Vannecke; A Deswaef; G A Verpooten; J Y Reginster
Journal:  Osteoporos Int       Date:  2008-06       Impact factor: 4.507

7.  Osteoporosis practice patterns in 2006 among primary care physicians participating in the NORA study.

Authors:  T W Weiss; E S Siris; E Barrett-Connor; P D Miller; C A McHorney
Journal:  Osteoporos Int       Date:  2007-06-19       Impact factor: 4.507

Review 8.  Hormone therapy for the prevention of bone loss in menopausal women with osteopenia: is it a viable option?

Authors:  Mary H Hohenhaus; Kelly A McGarry; Nananda F Col
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Does a history of non-vertebral fracture identify women without osteoporosis for treatment?

Authors:  Kathryn M Ryder; Steven R Cummings; Lisa Palermo; Suzanne Satterfield; Douglas C Bauer; Adrianne C Feldstein; John T Schousboe; Ann V Schwartz; Kristine Ensrud
Journal:  J Gen Intern Med       Date:  2008-05-06       Impact factor: 5.128

Review 10.  Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA).

Authors:  Nelson B Watts
Journal:  Osteoporos Int       Date:  2004-08-21       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.